Hines Lab Awarded NIAID R01

The Hines Lab was awarded an R01 from the National Institute for Allergy and Infectious Diseases (NIAID, 1R01AI173144) totaling $2.3 million to study the impacts of host-derived lipids on the antimicrobial susceptibilities of Staphylococcus aureus. This project includes collaborations with Dr. Michael Marty (U. Arizona), Dr. Brian Wilkinson (ILSTU), and Dr. Vineet Singh (ATSU) to address the impact of lipid composition on antibiotic-membrane interactions, antimicrobial susceptibilities in lipid-rich conditions, and murine infection model treatment outcomes, respectively.